NVOX logo

NVOX
Defiance Daily Target 2X Long NVO ETF

183
Volume
1.11M
52W High
$100.40
52W Low
$10.83
50D MA
$23.37
Prev Close
$10.92
Loading...
Loading...
News
all
press releases
News Placeholder
FDA Clears Popular Weight-Loss Drugs Of Suicide Risk After Review Of Over 100K Patients, Asks Drugmakers To Remove Warnings
The request applies to GLP-1 RAs approved for obesity, including Novo Nordisk’s Wegovy and Saxenda and Eli Lilly’s Zepbound.
Stocktwits·1mo ago
<
...
1
>

Latest NVOX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.